ARTICLE | Clinical News
Oncolym: Partner Alpha Therapeutic began Phase III trial
January 22, 1996 8:00 AM UTC
Techniclone International Corp. (TCLN), Tustin, Calif. Alpha Therapeutic Corp., Los Angeles, Calif. Product: Oncolym, Lym-1 antibody linked to 131 iodine Indication: B cell lymphoma Status: Partner ...